17
General Information
DRACP ID DRACP04816
Peptide Name 17
Sequence YXGFM
Sequence Length 5
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic
Disulfide/Other Bond Native peptide
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Cα -dialkylated glycine (Aaa2,2 )
Chiral L
Physicochemical Information
Formula C25H30N4O5S
Absent amino acids ACDEHIKLNPQRSTVW
Common amino acids FGMYX
Mass 68012
Pl 6.09
Basic residues 0
Acidic residues 0
Hydrophobic residues 1
Net charge 0
Boman Index 613
Hydrophobicity 60
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 1490
Absorbance 280nm 372.5
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16722632
Title Not available
Doi Not available
Year Not available
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
CancerPPD ID 3966
CancerPPD ID 3967
CancerPPD ID 3968
CancerPPD ID 3969
CancerPPD ID 3970
CancerPPD ID 3971
CancerPPD ID 3972
CancerPPD ID 3973
CancerPPD ID 3974
CancerPPD ID 3975
CancerPPD ID 3976
CancerPPD ID 3977
CancerPPD ID 3978
CancerPPD ID 3979
CancerPPD ID 3980
CancerPPD ID 3981
CancerPPD ID 3982
CancerPPD ID 3983
CancerPPD ID 3984
CancerPPD ID 3985
CancerPPD ID 3986
CancerPPD ID 3987
CancerPPD ID 3988
CancerPPD ID 3989
CancerPPD ID 3990
CancerPPD ID 3991
CancerPPD ID 3992
CancerPPD ID 3993
CancerPPD ID 3994